Improving adeno-associated vector yield in high density insect cell cultures.

Area of Science:

• Biotechnology
• Gene Therapy Vector Production
• Insect Cell Culture

Background:

• Recombinant adeno-associated virus (rAAV) vectors are crucial for gene therapy but face challenges in large-scale manufacturing.
• The baculovirus expression vector system (BEVS) offers a promising platform for producing rAAV in insect cells under serum-free conditions.

Purpose of the Study:

• To compare high and low multiplicity of infection (MOI) strategies for rAAV production in BEVS.
• To optimize rAAV production by evaluating low MOI combined with increased cell density and fed-batch cultivation.
• To validate the optimized production strategy in bioreactor settings.

Main Methods:

• Comparison of synchronous high MOI (>3 pfu/cell) versus low MOI (0.1 pfu/cell) baculovirus infection in shake flasks at 1.0 x 10(6) cells/ml.
• Evaluation of a low MOI strategy with an initial cell density of 5.0 x 10(6) cells/ml in fed-batch mode.
• Validation of the optimized production process in 3-L bioreactor runs.

Main Results:

• Low MOI infection, coupled with increased cell density, resulted in a 210% increase in rAAV titer (4.7 x 10(11) transducing units/L).
• The fed-batch approach led to a seven-fold enhancement in rAAV yield.
• Bioreactor production further increased rAAV yield by 25% compared to shake flask results, reaching 2.8 x 10(14) vector genomes/L.

Conclusions:

• The optimized BEVS process using low MOI and fed-batch strategies significantly enhances rAAV production efficiency.
• This high-yield production method addresses key limitations in current rAAV manufacturing.
• The BEVS system is positioned as a highly efficient platform for large-scale rAAV vector production.